TLR4 and silicosis: LPS further intensifies the blockade of AM autophagic degradation of silicosis patients via the activation of toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) and the toll-like receptor adaptor molecule 1 (TLRAM1) signaling pathway or inhibition of mTOR signaling pathway [26].